Herceptin Now Approved In The EU For Patients With HER2-positive Advanced Stomach Cancer

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has approved Herceptin (trastuzumab) in combination with chemotherapy for use in patients with HER2-positive metastatic stomach (gastric) cancer...Read original story

Leave a Reply

Security Code:

Search Alternative Cancer Remedy Reports!

Health Problem Solutions

Recommended Offers

Subscribe

Archives